Breast cancer survivors who regularly took aspirin after completing treatment were 50% less likely than survivors who did not take aspirin to die or have a recurrence, according to a study published Wednesday in the Journal of Clinical Oncology, USA Today reports (Szabo, USA Today, 2/17)...
More...